Indian pharmaceutical firms have pledged to invest more than Rs 5,260 crore, with the goal of generating 12,490 job openings within the pharmaceutical industry. The Telangana government has announced that six well-known pharmaceutical companies...
Lipella Pharmaceuticals Inc has reported the conclusion of dosing for the initial group in its multi-center phase 2a clinical trial for LP-310, a liposomal-tacrolimus oral rinse intended for treating oral lichen planus (OLP). In the initial group...
India has played a significant role in supplying cost-effective generic drugs, supporting healthcare systems worldwide for a considerable amount of time. Yet, worries have arisen about the provision of healthcare in countries relying on these...
The Indian pharmaceutical industry, known as the ‘pharmacy of the world’, has faced a trend of negative net voluntary licensing and technology transfers – constructive for medicine access in LMICs, according to the 2024 Access to Medicine Index. Rele
Marksans Pharma Limited has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg. These tablets are intended for over-the-counter (OTC) use to tre...
The rapid advancements in quality control techniques and testing methods have been driven by the rising need for safe, effective medications of high quality. The market is growing due to increased attention on product quality and adherence to...
The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2024 brought together over 290 professionals from leading pharmaceutical companies such as Roche, Johnson&Johnson, Moderna, Pfizer, Novartis, Takeda and other key players.
Elon Musk’s Neuralink announced on Wednesday that it has received approval to initiate its first clinical trial in Canada, focusing on a device designed to enable individuals with paralysis to control digital devices using their thoughts. The stud...
Long-term health management products, specifically chronic therapies, have been driving the growth of the Indian Pharmaceutical Market (IPM) with a 10% increase, in contrast to acute therapies which saw a 2% growth, showing a trend towards prolong...
The MHRA in the UK has given the approval to sparsentan (Filspari) for the treatment of IgAN. Berger's disease, or IgA neuropathy, is a kidney condition caused by the accumulation of immunoglobulin A (IgA) antibodies in the kidneys. Sparsentan...
, CDSCO.jpg)
